Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Ameren Corporation heads into its November 5 results with short interest climbing at an unusual pace for a regulated utility, even as the stock quietly outperforms its peers.
Short interest has become the standout data point this week. It rose 23% over the past seven days to reach 5.6% of the free float, a move that is hard to dismiss as noise. The absolute level is meaningful for a rate-regulated utility whose earnings are largely determined by regulators, not markets. Looking at the daily history, the build accelerated sharply after October 7, jumping from around 12.7 million shares to more than 15 million in barely a week. Yet the borrow market is not flashing stress: the cost to borrow has fallen 22% over the same period to a low 0.38%, and availability remains exceptionally loose, with roughly 11 shares available for every one already borrowed. That combination, rising short conviction alongside cheap and plentiful borrow, suggests the position is not a squeeze candidate. Shorts appear to be rebuilding deliberately, not fighting a crowded tape.
Options tell a calmer story. The put/call ratio has eased to 0.45, sitting fractionally below its 20-day average of 0.47. With a z-score near zero, options traders are neither particularly defensive nor particularly bullish. The ORTEX short score has moved in the same direction as the short interest build, climbing from 45.7 at the start of October to 49.6 on October 12, its highest level in the window, though still in the middle of the 0-to-100 range. The short score rank places Ameren in the 19th percentile of its universe, meaning most comparable stocks carry heavier short-side pressure.
Analyst sentiment is mixed and has been softening. Truist Securities cut its target from $120 to $116 on October 14, maintaining its Buy rating. Keybanc moved the other way a day earlier, lifting its target from $116 to $122 while holding an Overweight. Behind those two recent moves, the broader direction has been one of trimming: Mizuho and RBC both lowered targets in late September, Morgan Stanley cut twice in the past two months, and Scotiabank initiated at Sector Perform with a $104 target that sits close to the current price of $104.32. The mean analyst target of $116.81 implies about 12% upside from current levels. The bull case rests on regulated demand growth, with Missouri retail sales up 3% across customer classes. The bear case centres on the pacing of rate relief from Missouri's electric rate case and the dilutive effect of share issuance under forward sale agreements. Valuation multiples have been broadly stable over the past 30 days, with the P/E at 18.3x and EV/EBITDA at 11.2x, neither compellingly cheap nor stretched for the sector.
The stock's own operational data adds one colour point worth noting. EPA Clean Air Markets data showed the smallest June for gross capacity factor on record (since 2024), at 29.53%, for Ameren's power units. That is a factual reading for the last completed quarter, not a forecast. Separately, the nuclear output tracker from the US Nuclear Regulatory Commission shows reactor output running well below its own trailing history as of October 7, with a z-score of minus 4.8, the sharpest deviation in the dataset. This series has not been tested as a leading indicator of Ameren's revenue, so it is colour rather than signal, but a prolonged outage pattern heading into the winter quarter is worth monitoring alongside the November 5 print.
On the price tape, AEE rose 2.6% on the week to $104.32, matching closest peer WEC almost exactly at 2.6% and ahead of CNP at 2.1% and CMS at 1.9%. PEG was the outlier, down 1.8%. The institutional register is heavily concentrated: T. Rowe Price holds 11.8% of shares, its largest active manager position, and added nearly 3.9 million shares in the most recent reporting period. BlackRock added 2 million shares to hold 9.3%. No 13D activist is on the register. Insider flow in the 90-day window has been net negative at around 8,000 shares, with the most notable open-market activity a $708,000 sale by the Group President of Utilities in August under a pre-arranged 10b5-1 plan, reducing its informational weight considerably.
With earnings 22 days away and short interest at its highest point since early September, the key question before November 5 is whether the borrow build reflects a specific thesis on Missouri rate-case timing and share dilution, or simply reflects broader sector rotation pressure as interest rates remain a headwind for utility multiples.
See the live data behind this article on ORTEX.
Open AEE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
